Jürgen Drews
Presidente en Genaissance Pharmaceuticals, Inc. .
Origen de la red de primer grado Jürgen Drews.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.
53
| Subsidiary | Medical Specialties | 53 |
23
| Public Company | Biotechnology | 23 |
10
| Extinct | Biotechnology | 10 |
Genaissance Pharmaceuticals, Inc.
 Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT.
2
| Subsidiary | Biotechnology | 2 |
International Biomedicine Management Partners AG
1
| Extinct | Investment Managers | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jürgen Drews a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | General Counsel Chief Administrative Officer Sales & Marketing | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Operating Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Sales & Marketing | |
| ARQULE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chairman | |
| REGENXBIO INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Operating Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Analyst Corporate Officer/Principal | |
| George Washington University | College/University | Masters Business Admin Undergraduate Degree Graduate Degree Graduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| Rice University | College/University | Undergraduate Degree Undergraduate Degree | |
The Brookings Institution
 The Brookings Institution Miscellaneous Commercial ServicesCommercial Services The Brookings Institution provides research and policy solutions. The firm's activities are carried out through four research programs: economic studies, foreign policy studies, governance studies, and metropolitan policy. The company was founded in 1916 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
MdBio, Inc.
 MdBio, Inc. Miscellaneous Commercial ServicesCommercial Services MdBio, Inc. is based in Frederick, MD. MdBio provides medical-grade, patient-tested full spectrum hemp and plant-based medicine products that are unique in the industry for their innovation, quality, and potency. Targeting ailments such as poor sleep, anxiety, pain, and weakened immune systems, their products naturally restore the body's endocannabinoid balance to maximize overall health and wellbeing in patients. Part of Maryland Technology Council, MdBio, Inc. is a company founded by four renowned medical doctors committed to providing therapeutic alternatives to pharmaceutical drugs. MdBio was acquired by Tech Council of Maryland, Inc. on February 07, 2006. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Director/Board Member Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
| The University of Texas at Austin | College/University | Graduate Degree Doctorate Degree | |
| Indiana University | College/University | Masters Business Admin Doctorate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Director/Board Member Graduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Graduate Degree | |
| University of New Hampshire | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Chairman Human Resources Officer | |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| IMMATICS N.V. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
febit holding GmbH
 febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | Medical/Nursing Services | Director/Board Member Director/Board Member Chairman | |
| PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NANOSTRING TECHNOLOGIES, INC. | Biotechnology | Chairman Director/Board Member | |
Ariosa Diagnostics, Inc.
 Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Ariosa Diagnostics, Inc. offers diagnostics and genetic testing services. It focuses on improving overall patient care by developing and delivering genetic testing. The company was founded by John R. Stuelpnagel, Kenneth Song, Andrew J. Sparks, Michael E. Mitchell and Arnold R. Oliphant in 2008 and is headquartered in San Jose, CA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Founder | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Director of Finance/CFO | |
| BRAEBURN INC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director/Board Member | |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Consultant / Advisor Private Equity Investor | |
| EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Graduate Degree | |
PanOptica, Inc.
 PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Utrecht | College/University | Graduate Degree Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 39 |
| Alemania | 8 |
| Reino Unido | 3 |
| Suiza | 2 |
| Países Bajos | 2 |
Sectorial
| Health Technology | 23 |
| Consumer Services | 14 |
| Finance | 6 |
| Commercial Services | 6 |
| Health Services | 3 |
Operativa
| Director/Board Member | 599 |
| Corporate Officer/Principal | 239 |
| Independent Dir/Board Member | 164 |
| Chairman | 161 |
| Chief Executive Officer | 90 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Betsy Atkins | 82 |
| Augustine Lawlor | 43 |
| Argeris Karabelas | 42 |
| Laura Tyson | 42 |
| Christof Hettich | 40 |
| Perry Karsen | 38 |
| Friedrich von Bohlen und Halbach | 36 |
| William Young | 32 |
| Daniel Camus | 31 |
| Kathryn Falberg | 30 |
| Karin Eastham | 29 |
| Gerald Heinz Möller | 29 |
| Max E. Link | 28 |
| Colin Goddard | 26 |
| William A. Haseltine | 24 |
- Bolsa de valores
- Insiders
- Jürgen Drews
- Conexiones Empresas
